ATOSSA THERAPEUTICS INC
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
ATOS$2.14+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)
The following documents are filed as a part of this Annual Report:
- Financial Statements
| Report of Independent Registered Public Accounting Firm (EY; PCAOB ID #42) | 61 |
|---|---|
| Report of Independent Registered Public Accounting Firm (BDO USA, LLP; Seattle, Washington; PCAOB ID #243) | 63 |
| Consolidated Balance Sheets | 64 |
| Consolidated Statements of Operations | 65 |
| Consolidated Statements of Stockholders' Equity | 66 |
| Consolidated Statements of Cash Flows | 67 |
| Notes to Consolidated Financial Statements | 68 |
- Financial Statement Schedules
All financial statement schedules are omitted because they are not required or the required information is included in the consolidated financial statements or notes thereto.
- Exhibits
See the Exhibit Index on page 80 of this report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.